The question is asking about the management options for a patient with End-Stage Renal Disease (ESRD) due to ANCA-associated vasculitis. 

Option A suggests that patients with ESRD due to ANCA-associated vasculitis have inferior survival while using hemodialysis compared with patients with ESRD from other causes. However, survival rates on hemodialysis are not specifically linked to the cause of ESRD, but rather to the overall health status of the patient and other comorbidities.

Option B suggests that patients with ESRD due to ANCA-associated vasculitis who receive a kidney transplant consistently have inferior allograft survival compared with patients receiving transplants for other reasons. This is not necessarily true. The success of a kidney transplant depends on many factors, including the match between donor and recipient, the recipient's overall health, and the management of immunosuppression.

Option D suggests that because the patient did not have lung or upper respiratory vasculitis, her chances of disease relapse while she is using dialysis are lower. However, the risk of disease relapse is not necessarily linked to the presence or absence of lung or upper respiratory vasculitis.

Option C suggests that because the patient is still ANCA positive, transplantation should be delayed until she is ANCA negative for at least 6 months because of a higher risk of disease recurrence. This is the most accurate statement. ANCA positivity is associated with a higher risk of disease recurrence in ANCA-associated vasculitis. Therefore, it is often recommended to delay transplantation until the patient is ANCA negative to reduce the risk of disease recurrence.

Therefore, the answer is [C].